Common cold is one of the most frequent human inflammatory diseases caused by viruses and can facilitate bacterial super-infections resulting in sinusitis or pneumonia. The active ingredient of the drug Soledum, 1,8-cineole, is commonly applied for treating inflammatory diseases of the respiratory tract. However, the potential of 1,8-cineole for treating primary viral infections of the respiratory tract remains unclear.
Introduction
The common cold syndrome is one of the most frequent inflammatory diseases, averagely affecting an adult two to four times per year (reviewed in (1) ). Infection of the respiratory tract by rhinoviruses (2) , or to a lesser extent by coronaviruses or influenza viruses is followed by typical symptoms ranging from sneezing, sore throat, cough and nasal congestion to tiredness and malaise (3, 4) . In addition, common cold has been reported to lead to an increase of acute exacerbations in patients with asthma and chronic obstructive pulmonary disease (COPD) (5) (6) (7) . The damage of respiratory epithelium during viral infection further facilitates bacterial infections of the respiratory tract and subsequent inflammatory diseases like sinusitis and pneumonia (reviewed in (1) ). Natural, plant-derived monoterpenoids are commonly applied for treatment of inflammatory diseases of the respiratory tract (8) . Initially identified by Cloez in 1870 as the dominant portion of Eucalyptus globulus oil (9), the monoterpenoid 1,8-cineole was described to have an anti-bacterial activity (10, 11) as well as anti-inflammatory effects in animal models of allergic airway inflammation (12, 13) and acute pulmonary inflammation (14) . 1,8-cineole is currently therapeutically applied as the active ingredient of the drug Soledum. Placebocontrolled, double blind trials demonstrated an effective treatment of acute sinusitis with 1,8-cineole in 152 patients (15) . Worth and colleagues further demonstrated 1,8-cineole to improve lung function and reduce exacerbations in 242 patients suffering from COPD (16) . Likewise, Juergens et al. showed beneficial effects of 1,8-cineole in 12 of 16 patients with bronchial asthma (17, 18) . Indicating a potential molecular mechanism by cytokine inhibition, 1,8-cineole reduced the production of pro-inflammatory cytokines TNFα and IL1β in human monocytes (19) . We extended these findings by demonstrating that 1,8-cineole inhibits the activity of the transcription factor nuclear factor kappa light chain enhancer of activated Bcells (NF-κB), a key mediator of pro-inflammatory signalling. In particular, we showed a 1,8-cineole-dependent reduction of nuclear translocation of NF-κB p65 and decreased NF-κB-dependent transcriptional activity (20) . This novel mode of action was recently confirmed by Zhao and co-workers, who showed a NF-κB-associated reduction of pro-inflammatory cytokines after 1,8-cineole-treatment in the mouse system in vivo (14) . Despite these promising effects against bacteria-induced inflammation, the potential effect of 1,8-cineole for treating the predisposing viral infection remains unclear. In the present study, we applied the double-stranded RNA analogue Poly(I:C) (polyinosinic:polycytidylic acid) to mimic viral infection in vitro and ex vivo. Poly(I:C) is broadly described to induce antiviral responses in a broad variety of cell types such as human alveolar, corneal and bronchial epithelial cells (21, 22) as well as in the lung of mice (23) . Poly(I:C) is recognized by Toll-like receptor 3 (TLR3), in turn leading to a cellular antiviral response via activation of the MyD88-independent signalling pathway culminating in activation of IRF3 and production of type I interferons (IFN). In addition to activation of IRF3, MyD88-independent signalling results in a late and weak activation of NF-κB followed by a moderate release of pro-inflammatory cytokines (24, 25) . Notably, Wang et al. reported in 2009 a TLR3-mediated recognition of rhinoviral dsRNA intermediates in rhinovirus-infected airway epithelial cells (26) , highlighting the suitability of Poly(I:C) to mimic rhinoviral infection. In the present study, we determined potential effects of 1,8-cineole on antiviral IRF3-activity using human cell lines and human nasal stem cells isolated from the inferior turbinate. ITSCs represent a promising cellular model system due to their easy expandability and their endogenous niche within the respiratory epithelium (27, 28) . Next to cellular models, we described very recently the successful application of ex vivo cultivated human nasal slices from the inferior turbinate as a novel model system of the late phase of rhinosinusitis. Here, treatment with 1,8-cineole significantly reduced the amount of Alcian Blue-stained mucin within goblet cells. Accordingly, we observed a significant reduction of MUC2 gene expression in ex vivo cultivated nasal slices accompanied by attenuated expression levels of TNFα (29) . In the present study, we demonstrate for the first time that 1,8-cineole leads to elevated levels of antiviral IRF3-activity in human cell lines, ITSCs as well as in ex vivo cultivated human nasal tissue in a viral mimic model. In particular, Poly(I:C)-treatment of human cell lines resulted in increased activity, nuclear translocation and respective target gene expression of IRF3 and NF-κB. Exposure to Poly(I:C) and 1,8-cineole led to significantly increased IRF3-activity, accompanied by reduced nuclear translocation of NF-κB p65 and diminished NF-κB-activity. Notably, nuclear translocation of IRF3 was significantly increased in ITSCs and nasal slice cultures treated with Poly(I:C) and 1,8-cineole in comparison to the Poly(I:C)-treated approaches. Moreover, LPS-treatment of human nasal slice cultures led to an increased activity of IRF3, which was further significantly increased after co-treatment with 1,8-cineole.
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Materials and Methods
Cell culture
Human cell lines U373 and U251 were cultivated in DMEM High Glucose (Sigma-Aldrich, cat. No. D5671, Taufkirchen, Germany) containing 1% L-Glu (200 mM; Sigma-Aldrich, Taufkirchen, Germany) and 10 % fetal calf serum (FCS, lot: 126K3398, Sigma-Aldrich, Taufkirchen, Germany) in a humidified incubator (Binder, Tuttlingen, Germany) at 37 °C and 5 % CO 2 . ITSCs were isolated from inferior turbinates obtained during nasal surgery after an informed consent according to local and international guidelines (Bezirksregierung Detmold/ Münster). Isolation and further experimental procedures were ethically approved by the ethics commission of the Ärztekammer Westfalen-Lippe and the medical faculty of the Westfälische Wilhems-Universität (Münster, Germany) (approval reference number 2012-15-fS). Isolation and cultivation procedures were performed as described in Hauser et al. (27) . U373 and U251 cells as well as ITSCs were treated with Poly(I:C) (polyinosinic-polycytidylic acid sodium salt, 100 µg/ml, cat. No. P1530, Sigma Aldrich), LPS (Lipopolysaccharides, 1 μg/ml, rough strains from Salmonella enterica Re 595, cat. no. L9764, Sigma-Adrich St. Louis, MO, USA), or LPS/Poly(I:C) and 1,8-cineole (10 -4 M, prepared as described in Greiner et al (20) , Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany).
Tissue culture of nasal turbinate slices
Human nasal inferior turbinates were isolated during nasal surgery after an informed consent according to local and international guidelines (Bezirksregierung Detmold/ Münster). Isolation and further experimental procedures were ethically approved by the ethics commission of the Ärztekammer Westfalen-Lippe and the medical faculty of the Westfälische WilhemsUniversität (Münster, Germany) (approval reference number 2012-15-fS). Sliced Inferior turbinate tissue (200µm thickness) was transferred to culture plate inserts (0.4 µm nitrocellulose membrane, Millipore/Greiner, Billerica, MA, USA) and cultivated at the interface of air and B-ALI differentiation medium (Lonza, Basel, Switzerland) as previously described (29) . Nasal slices were cultured for at least one week followed by treatment with LPS (100 ng/ml, rough strains from Salmonella enterica Re 595, cat. no. L9764, Sigma-Adrich St. Louis, MO, USA), or co-treatment with LPS and 1,8-cineole (10 -4 M, Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany) for 24 h followed by immunohistochemistry as described below. Treatment of nasal slice cultures with Poly(I:C)-(100 µg/ml, Sigma Aldrich) or Poly(I:C) and 1,8-cineole (10 -4 M, Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG) was performed for 2 h and 4 h followed by immunohistochemistry as described below.
Transient transfection and gene reporter assays
U373 and U251 cells were transfected with 2.2 µg pRL-CMV (Promega Cooperation, Mannheim, Germany) and 1.1 µg TK (NF-κB) 6 LUC (30) for NF-κB reporter gene assays or 2.2 µg pRL-CMV (Promega Cooperation, Mannheim, Germany) as well as 1µg IRF3-Gal4 and 1µg UAS-LUC (kindly provided by Katherine A. Fitzgerald, Department of Medicine, University of Massachusetts Medical School, Worcester, USA). Transfection was performed using rat NSC Nucleofector Kit (Amaxa Biosystems, Lonza Group AG, Basel, Switzerland) and Nucleofector II device (Lonza Group) according to manufacturer's guidelines. FPred (1.5 µg, Lonza Group, Basel, Switzerland) or pmaxGFP (0.3 µg, Lonza Group, Basel, Switzerland) served as transfection control. 24 h after transfection, U373 and U251 cells were treated with Poly(I:C) (Sigma Aldrich), LPS (1 μg/ml, rough strains from Salmonella enterica Re 595, Sigma-Adrich), or combinations of LPS/Poly(I:C) and 1,8-cineole (1x10 -4 M or 2x10 -4 M prepared as described in Greiner et al (20) , Klosterfrau Healthcare Group) for 24 h. Luciferase activity was subsequently assessed by applying Dual-Luciferase® Reporter Assay System (Promega Corporation, cat. no. E1960) according to manufacturer's guidelines. Statistical analysis was performed using GraphPad Prism software (GraphPad Software, La Jolla, CA, USA), bioluminescence of constitutively active Renilla luciferase (pRL-CMV vector) served for normalization.
Reverse transcription PCR
Total RNA was isolated from untreated and Poly(I:C)-treated U251 cells , and peripheral blood monocytes (PBMCs) as described above using RNeasy Mini Kit (QIAGEN, Hilden, Germany) according to manufacturer's guidelines or via phenol-chloroform extraction. PBMCs (no. 090928AUK136/02) were kindly provided by Cellular Therapy Centre, Medical School Hannover, Hannover, Germany (informed consent was provided to Klinikum Bielefeld, Bielefeld, Germany). Quality and concentration of RNA was determined using Nanodrop UV spectrophotometry followed by cDNA synthesis via application of First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, cat. No. K1612, Darmstadt, Germany) according to manufacturer's guidelines. PCR was performed using GoTaq Polymerase (Promega Cooperation, Mannheim, Germany) according to manufacturer's guidelines. For primer sequences (0.5 µM, Metabion, Martinsried, Germany) see Table 1 .
Real Time PCR
Total RNA was isolated from ITSCs treated as described above using RNeasy Mini Kit (QIAGEN, Hilden, Germany) followed by cDNA synthesis with qSqript cDNA Synthesis Kit (Quanta, Gaithersburg, MD, USA) according to manufacturer's guidelines. All qPCR reactions were performed as triplicate using 5x EvaGreen® QPCR-Mix II (Bio-Budget Technologies GmbH, Krefeld, Germany) according to manufacturer's guidelines and assayed with a Rotor Gene 6000 (QIAGEN). Primer sequences (0.5 µM, Metabion, Martinsried, Germany)
were CCCTCGCTGTCATCCTCATT (RANTES forward), ACGACTGCTGGGTTGGAG (RANTES reverse), CTGCACCACCAACTGCTTAG (GAPDH forward) and GTCTTCTGGGTGGCAGTGAT (GAPDH reverse).
Immunocytochemistry
For immunocytochemistry, U251 cells, U373 cells, and ITSCs treated as described above were fixed using 4 % paraformaldehyde (PFA, 4 % paraformaldehyde, 100 mM NaH 2 PO 4 , 0.4 mM CaCl 2 ) for 20 minutes followed by permeabilization and blocking with 0.02 % PBT (0.02 % TritonX-100 (Sigma-Aldrich cat. No. T8787, Taufkirchen, Germany) in PBS) comprising 5 % goat serum (Dianova, Hamburg, Germany). Primary antibodies anti-NF-κB-p65 (sc-372 or sc8008, Santa Cruz Biotechnologies) or anti-IRF3 (sc-9082, Santa Cruz Biotechnologies) were applied for 1 h. Respective secondary fluorochrome-conjugated antibodies (A21428, A21422, A21201, Molecular Probes, Göttingen, Germany) were subsequently added for 1 h under exclusion of light. Nuclear counterstaining was performed by applying 4′,6-Diamidin-2-phenylindol (DAPI; 1:2000, Life Technologies, Darmstadt, Germany) for 15 min followed by covering with mowiol. Fluorescence imaging was done using confocal scanning microscopy (LSM 780, Carl Zeiss, Jena, Germany) and ZEN software (Carl Zeiss). Image processing and analysis were performed using Fiji (31) followed by statistical analysis with GraphPad Prism software (GraphPad Software, La Jolla, CA, USA).
Immunohistochemistry
Nasal slices cultivated and treated as described above were removed from the culture inserts followed by preparation of 10 µm thick cryosections. For immunohistochemistry, 4 % PFA was applied for 20 minutes followed by permeabilization and blocking with 0.1 % PBT (Sigma-Aldrich) comprising 5 % goat serum (Dianova) and addition of primary antibodies anti-NF-κB-p65 (sc-372 or sc8008, Santa Cruz Biotechnologies), anti-IRF3 (sc-9082, Santa Cruz Biotechnologies) or anti-CK14 (sc-7156, Santa Cruz Biotechnologies) for 2 h. Respective secondary fluorochrome-conjugated antibodies (A21428, A21422, A21201, Molecular Probes) were subsequently applied for 1 h under exclusion of light. Nuclear counterstaining was done using DAPI (1:2000, Life Technologies) for 15 min followed by covering with mowiol. Fluorescence imaging was done via confocal scanning microscopy (LSM 780, Carl Zeiss) and ZEN software (Carl Zeiss) followed by image processing and analysis using Fiji (31) . Statistical analysis was performed using GraphPad Prism software (GraphPad Software).
Results
Poly(I:C)-driven mimicry of viral infection increases activity of NF-κB and IRF3
Assessing the presence of protein transcripts relevant for NF-κB-and IRF3-signalling in U251 cells, we showed expression of Toll-like receptor 3 and 4 (TLR3, TLR4), cluster of differentiation 14 (CD14), Lymphocyte antigen 96 (MD2), Myeloid differentiation primary response gene 88 (MYD88), TIR-domain-containing adapter-inducing interferon-β (TRIF), Toll/interleukin-1 receptor domain-containing adapter protein (TIRAP) and TRIF related adapter molecule (TRAM) (Fig. 1A) . In order to mimic viral infection in U251 cells, we applied the double strand RNA analogue Poly(I:C) to simulate the presence of dsRNA replication intermediates of single strand RNA viruses (24, 26) . U251 cells transiently transfected with a dual luciferase NF-κB-reporter system showed a significant increase in luciferase activity after treatment with increasing concentrations of Poly(I:C) (25 -1000 µg / ml) in comparison to untreated control. In addition, we observed significantly augmented luciferase activities compared to control in response to Poly(I:C) (25 -1000 µg / ml) in U251 cells transiently transfected with a IRF3-driven luciferase reporter system (Fig. 1B) .
Significantly increased nuclear translocation of IRF3 and NF-κB p65 after Poly(I:C)-treatment is accompanied by an increased expression of IRF3 and NF-κB target genes
Validating the increase in sustained IRF3-and NF-κB-activity, we showed an augmented nuclear translocation of IRF3 and NF-κB p65 in U251 cells after Poly(I:C)-treatment compared to the control (Fig. 1C, Fig. S1, Fig. S2 ). Quantification of immunocytochemical stainings confirmed the increase in the amount of nuclear IRF3 after 2 h and 4 h of Poly(I:C)-treatment. Accordingly, significantly elevated nuclear translocation of NF-κB p65 was observed in U251 cells treated with Poly(I:C) for 2 h in comparison to control (Fig. 1D) . RT-PCR analysis further demonstrated increased expression of IRF3 target genes Regulated on Activation, Normal T cell Expressed and Secreted (RANTES) and interferon-β (IFN-β). In addition, we detected an elevated expression of the NF-κB target gene tumour necrosis factor α (TNFα) in Poly(I:C)-treated U251 cells compared to untreated control (Fig. 1E ).
Poly(I:C)-induced activity of IRF3 is further increased by co-treatment with 1,8-cineole
To investigate potential effects of 1,8-cineole on IRF3 after Poly(I:C)-mediated simulation of viral infection we transiently transfected U373 cells with a dual IRF3 luciferase reporter system. Poly(I:C)-treatment of U373 cells transiently transfected with the dual IRF3-reporter system led to significantly increased luciferase activity in comparison to control. Although we observed no effects of 1,8-cineole alone (Fig. S3A) , combination of Poly(I:C) and 1,8-cineole led to a further increase of luciferase activity if compared to Poly(I:C)-treated cells ( Fig. 2A) .
1,8-cineole leads to strongly reduced nuclear translocation of NF-κB p65 as well as significantly reduced levels of NF-κB-activity after Poly(I:C)-treatment
Next, we determined the effects of 1,8-cineole on NF-κB after Poly(I:C) stimulation. Luciferase activity in U251 cells transiently transfected with a dual NF-κB-reporter system showed an increase of NF-κB-activity after Poly(I:C)-treatment in comparison to control. Cotreatment with 1,8-cineole resulted in significantly decreased luciferase activity compared to Poly(I:C)-treated cells ( Fig. 2A) , demonstrating the reduction of pro-inflammatory NF-κB-activity by 1,8-cineole in a model of viral infection. Treatment of U373 cells with Poly(I:C) similarly resulted in increased nuclear translocation of NF-κB p65 compared to the untreated control. Moreover, we observed a significantly decreased nuclear localization of NF-κB p65 after exposure of U373 cells to Poly(I:C) and 1,8-cineole in comparison to Poly(I:C)-stimulated cells (Fig. 2C-D) . No differences to control were observed in cell treated with 1,8-cineole alone (Fig. S3B) .
1,8-cineole-treatment results in significantly augmented IRF3-activity and reduced activity of NF-κB p65 after LPS-stimulation
In order to investigate the activity of IRF3 after LPS-treatment, U373 cells were transiently transfected with a dual IRF3-reporter system. Here, we detected significantly higher luciferase bioluminescence after LPS-treatment compared to untreated control. U373 cells co-treated with LPS and 1,8-cineole showed a further increase in IRF3-activity in comparison to cells treated with LPS alone (Fig. 2B) . A dual luciferase reporter gene assay revealed significantly increased NF-κB-activity after treatment with LPS in comparison to control. Co-treatment with 1,8-cineole resulted in a significant decrease in luciferase activity compared to the cells exposed to LPS alone (Fig.  2B ). In accordance with our previous findings (20), we observed significantly reduced amounts of nuclear NF-κB p65 after treatment with 1,8-cineole and LPS compared to LPSstimulation alone (data not shown).
Poly(I:C) leads to increased nuclear translocation of IRF3 and NF-κB in ITSCs
With regards to the endogenous environment of rhinosinusitis, we applied stem cells isolated from the respiratory epithelium of adult human inferior turbinate (Fig. 3A-B) to further determine potential effects of 1,8-cineole on the activity of IRF3 and NF-κB. Validating the suitability of ITSCs to investigate Poly(I:C)-and LPS-induced activation of IRF3 and NF-κB, we showed expression of TLR3 and TLR4 in ITSCs isolated from three independent donors (Fig. 3C) . Exposure of ITSCs to Poly(I:C) for 2 h resulted in significantly increased nuclear translocation of IRF3 accompanied by highly elevated amounts of nuclear localized NF-κB p65 in comparison to control (Fig 3D-F) .
Co-treatment of ITSCs with Poly(I:C) and 1,8-cineole results in increased IRF3-activity accompanied by significantly reduced activity of NF-κB
ITSCs were co-treated with 1,8-cineole and Poly(I:C) as described above and subjected to immunocytochemical analysis of nuclear IRF3 and p65. Here, co-treatment of ITSCs with Poly(I:C) and 1,8-cineole led to significantly increased nuclear translocation of IRF3 in comparison to Poly(I:C)-stimulation ( Fig. 3D-E) . However, a significant decrease in the amount of nuclear localized NF-κB p65 was observed in ITSCs exposed to Poly(I:C) and 1,8-cineole compared to Poly(I:C)-treated cells (Fig. 3D,3F ).
1,8-cineole leads to significantly decreased nuclear localization of NF-κB p65 in LPStreated ITSCs
ITSCs were exposed to LPS to mimic bacterial infection common during late rhinosinusitis. LPS-treatment of ITSCs for 2 h led to an increased nuclear translocation of NF-κB p65 compared to control (Fig. 4A) . Co-treatment with 1,8-cineole resulted in a significant decrease of nuclear NF-κB p65 in comparison to Poly(I:C)-stimulation (Fig. 4B) . Notably, we observed no changes of nuclear translocation of IRF3 and NF-κB after treatment with 1,8-cineole alone (Fig. S3C) .
Expression of the IRF3-target gene RANTES is elevated in ITSCs after treatment with 1,8-cineole in a model of superinfection
As a model of superinfection, ITSCs were pre-treated with Poly(I:C) for 4 h followed by coexposure to Poly(I:C) and LPS for 20 h. In comparison to control, significantly increased expression levels of the IRF3 target gene RANTES were observed after simulation of superinfection (Fig. 4C) . Co-treatment of ITSCs with Poly(I:C), LPS and 1,8-cineole led to further increase in RANTES expression compared to Poly(I:C)/LPS-stimulation (Fig. 4C) .
1,8-cineole leads to increased nuclear IRF3 and decreased nuclear translocation of NF-κB p65 in ex vivo human nasal turbinate slices stimulated with Poly(I:C)
We investigated potential effects of 1,8-cineole on IRF3-activity in ex vivo cultivated human nasal turbinate tissue treated with Poly(I:C). Cultured nasal turbinate tissue remained an intact epithelial layer demonstrated by expression of CK14 at protein level (Fig. S3A) . After 2 h of Poly(I:C)-treatment, turbinate tissue revealed slightly increased amounts of nuclear IRF3, which were further elevated after co-treatment with 1,8-cineole (Fig 5A) . Quantification of nuclear fluorescence intensities in the immunohistochemical stainings revealed a statistically significant increase in nuclear translocation of IRF3 after co-treatment of nasal slice cultures with Poly(I:C) and 1,8-cineole in comparison to control and Poly(I:C)-treated human nasal slices (Fig. 5B) . In contrast to the fast kinetics of Poly(I:C)-dependent activation of IRF3 observed in ITSCs (2 h, Fig. 3D-E) , Poly(I:C)-treatment of ex vivo cultivated human nasal slices resulted in a delayed, but significantly increased nuclear translocation of IRF3 after 4 h (Fig 5C) . In addition, we observed further increased amounts of nuclear localized IRF3 after co-treatment with Poly(I:C) and 1,8-cineole compared to Poly(I:C)-treated slices (Fig 5C) . Statistically significant increase in nuclear IRF3 was observed after co-treatment of nasal slice cultures with Poly(I:C) and 1,8-cineole in comparison to control (Fig. 5D ). Besides the increased activity of IRF3, we observed significantly increased nuclear translocation of NF-κB in Poly(I:C)-treated nasal slice cultures compared to control after 2 h (Fig. 6 ). Co-treatment with 1,8-cineole and Poly(I:C) for 2 h resulted in significantly decreased nuclear NF-κB compared to slices treated with Poly(I:C) alone (Fig. 6 ).
Co-treatment of nasal slice cultures with 1,8-cineole and LPS leads to nuclear translocation of IRF3 and decrease of nuclear NF-κB
In a model of late rhinosinusitis, nasal slice cultures were treated with LPS followed by analysis via immunohistochemistry. We observed an increase in nuclear IRF3 after exposure to LPS, and a further increase in nasal slices co-treated with 1,8-cineole (Fig. 7A , middle panels). LPS-treatment resulted in an increased nuclear translocation of NF-κB in human nasal slice cultures, which was highly decreased after co-treatment with 1,8-cineole (Fig. 7A,  right panels, Fig. S4A ). We quantified the nuclear fluorescence intensities in the immunohistochemical stainings and showed a statistically significant increase in nuclear translocation of IRF3 after co-treatment of nasal slice cultures with LPS and 1,8-cineole in comparison to control (Fig. 7B ). The amount of nuclear NF-κB after LPS stimulation was significantly decreased after co-treatment with 1,8-cineole (Fig. 7C, Fig. S4B-C) .
Discussion
Model systems of airway diseases include cellular models, such as primary cultures and cell lines of human tracheal or nasal epithelium. In an alveolar epithelial cell line and a bronchial epithelial cell line treated with double-stranded RNA and influenza A virus Guillot and coworkers showed immune response via secretion of the cytokines IL-8, RANTES and IFN-β (21) . Moreover, primary cell cultures of human tracheal or nasal epithelium infected with rhinoviruses further revealed increased levels of viral RNA and a release of infectious particles (32). In the present study, ITSCs were successfully applied as a novel stem cell model of airway diseases. Next to their great potential for regenerative medicine (33), ITSCs are easily expandable and remain their genetic stability during cultivation (28) . Notably, these cells are endogenously located within the respiratory epithelium of the human inferior turbinate (27) , further emphasizing their applicability for pharmacological research of the upper respiratory tract. Next to these promising cellular model systems, mouse models are broadly used to simulate airway diseases in vivo (34), although potential differences in the upstream signalling of the antiviral response may question the transferability to the human system (35) . Facing this challenge, organ slice cultures remain promising alternatives in terms of resembling the endogenous niche. Here, Switalla and colleagues showed normal innate cytokine response to immunomodulators in human precision-cut lung slices (36) . Likewise, increased immune responses were observed in human lung slices infected with influenza virus (37) , enabling the application of the model system to functionally test inhalable nanoparticle based influenza vaccine (38) . Primary human nasal tissue cultures applied in the present study closely resemble the complex architecture of the endogenous niche including an intact ciliated epithelial surface comprising acetyl-α-tubulin-positive cilia, a basal membrane and mucus-filled goblet cells (29) . Arruda et al. showed replication of human rhinovirus to occur in the upper respiratory tract, in particular within the nasal epithelium and the nasopharynx (39) , underlining the suitability of the here applied stem cell and tissue model systems for mimicking rhinoviral infection.
To simulate rhinoviral infection in ex vivo cultivated human nasal tissue as well as human stem cells and cell lines, Poly(I:C) was applied. This dsRNA analogue is described to mediate antiviral responses in a broad range of cell types (21) (22) (23) as well as in the mouse system after intraperitoneal administration (40) . On molecular level, both rhinoviral dsRNA intermediates and Poly(I:C) are recognized via TLR3, which in turn leads to activation of the MyD88-independent signalling pathway resulting in recruitment of TRIF (TIR-domaincontaining adapter-inducing interferon-β) and activation of IRF3. Active IRF3-dimers translocate into the nucleus and regulate the expression of IFN-β and RANTES, thereby mediating the cellular antiviral response (25) . In addition to mediation of the IRF3-activation, TRIF is also able to activate a late and weak NF-κB response through TRAF6. Activation of NF-κB is followed by expression of its target genes including the pro-inflammatory cytokine TNFα. Accordingly, we observed an increase in antiviral IRF3-and pro-inflammatory NF-κB-activity accompanied by elevated expression of IFN-β, RANTES and TNFα after Poly(I:C)-treatment. Co-treatment with Poly(I:C) and 1,8-cineole led to significantly increased IRF3-activity, whereas NF-κB-activity was significantly reduced in comparison to Poly(I:C)-treated cells. These findings are in general accordance with other studies, hence terpenoids are known to possess direct antiviral properties (reviewed in (41)). In particular, α-terpinene, γ-terpinene, α-pinene and also 1,8-cineole were shown to have an antiviral activity against the DNA virus herpes simplex virus type 1 (HSV-1) by directly inactivating free virus particles (42). Chiang and co-workers further described a broad range of antiviral activity of the terpenoid alcohol linalool and the triterpenoid ursolic acid, namely against adenoviruses, hepatitis B virus, coxsackievirus B1 and enterovirus 71 (43) . Next to mimicking viral infection, we applied LPS to simulate secondary bacterial infection common during late rhinosinusitis (44) . Consistent with our previous findings (20, 29) and the broadly described anti-inflammatory activity of monoterpenoids (reviewed in (45)), LPS-treatment led to significantly increased NF-κB-activity, which was significantly decreased after co-treatment with 1,8-cineole. Likewise to Poly(I:C)-mediated MyD88-independent signalling, IRF3 can be activated by LPS in a TRIF-dependent manner. Here, recognition of LPS by the Toll-like receptor 4 (TLR4) is followed by recruitment of TRIF, in turn leading to nuclear translocation of IRF3 and expression of respective target genes (46) . In the present study, we observed an increased nuclear translocation of IRF3 in human nasal slice cultures after LPS-stimulation. Co-treatment with 1,8-cineole significantly increased the amount of nuclear IRF3, suggesting an antiviral activity of 1,8-cineole during late rhinosinusitis. Moreover, 1,8-cineole led to significantly elevated expression levels of the IRF-3 target gene RANTES in Poly(I:C)-pre-treated ITSCs after additional co-treatment with LPS and Poly(I:C) mimicking bacterial superinfection. The potential therapeutic impact of activating IRF3-mediated antiviral responses while simultaneously inhibiting pro-inflammatory NF-κB-signalling was impressively shown by Bartlett and coworkers. In particular, the authors demonstrated reduced inflammation but unchanged antiviral responses in vivo in rhinovirus-infected mice lacking NF-κB-p65. However, Interferon α-receptor 1-deficient mice infected with rhinoviruses showed elevated levels of rhinovirus replication and decreased antiviral responses, suggesting a new therapeutic strategy against rhinoviral infection via reduction of NF-κB-dependent proinflammatory signalling accompanied by increased antiviral IFN-signalling (47) . Next to common cold syndromes, rhinovirus infections also increase acute exacerbations in asthma patients (6) . Rhinovirus-induced asthma is often accompanied by glucocorticoid resistance in an NF-κB-dependent manner, resulting in inefficient treatment of asthma exacerbations (48) . Since 1,8-cineole is already established for treating steroid-dependent asthma (17) , the here observed IRF3-dependent anti-viral activity of 1,8-cineole in addition to the already described inhibitory effects on NF-κB-signalling (20) may further broaden its range of application.
In summary, this study demonstrates for the first time that 1,8-cineole, which is clinically approved as the active ingredient of Soledum, activates IRF3-mediated antiviral response in a human ex vivo model of rhinosinusitis. Our findings may broaden the range of clinical applications of 1,8-cineole, particularly in terms of treating the common cold syndrome and related ssRNA virus-dependent airway infections.
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Clinical perspectives
Although the common cold syndrome is one of the most frequent virally caused human diseases and can facilitate severe secondary infections like sinusitis or pneumonia, treatment strategies often do not target the underlying viral infection.
Applying ex vivo cultivated human nasal tissue as a model system of rhinosinusitis, we demonstrate here that 1,8-cineole, the active ingredient of the drug Soledum, potentiates the antiviral activity of IRF3 in addition to its inhibitory effect on pro-inflammatory NF-κB-signalling.
The antiviral activity of 1,8-cineole shown in the present study may broaden its range of applications particularly in terms of treating the common cold syndrome and related rhinovirus-dependent airway infections. Significantly increased luciferase activity in U373 cells transiently transfected with NF-κB-dependent luciferase reporters after exposure to Poly(I:C) was significantly decreased after co-treatment with 1,8-cineole. (***p<0.001, **p<0.01 and *p<0.05 was considered significant, unpaired t-test, two tailed, confidence interval: 95%. Data merged from two independent measurements.) (B) Treatment with LPS resulted in significantly increased luciferase activity in U373 cells transiently transfected with IRF3-luciferase reporters compared to untreated control. Co-treatment with LPS and 1,8-cineole resulted in significantly increased amounts of luciferase activity compared to the LPS-treated cells. U373 cells transiently transfected with NF-κB-driven luciferase reporters showed significantly increased luciferase activity after LPS-treatment, which was significantly decreased after cotreatment with 1,8-cineole. (***p<0.001 and **p<0.01 was considered significant, unpaired ttest, two tailed, confidence interval: 95%). Data merged from two independent measurements. (C-D) Amount of nuclear localized NF-κB p65 was significantly reduced in U373 cells after co-treatment with Poly(I:C) and 1,8-cineole in comparison to Poly(I:C)-stimulation for 2 h (immunocytochemical stainings displayed as intensity scale; ***p<0.001 was considered significant, unpaired t-test, two tailed, confidence interval: 95%). Quantification of fluorescence intensities of the immunohistochemical stainings revealed a significant increase in the amount of nuclear localized NF-κB p65 in the whole epithelial layer and specifically in ciliated as well as in basal cells after LPS-treatment, which was significantly decreased after co-treatment with 1,8-cineole (***p<0.001, unpaired t-test, two tailed, confidence interval: 95%).
